Conclusion: Probability of developing BSI in adults undergoing ECMO increases with ECMO duration.
Recently, another study demonstrated the value of BSI in patients with castration-resistant prostate cancer [13].
Evaluation of the prognostic additive value of BSI in PCa patients during ADT was thus of interest.
Finally, the large accumulation of BSi in salt marshes points to a strong role of biology in the Si cycle.
Concordance index (C-index) was used to evaluate the discriminating strength of automated BSI in predicting OS.
The result demonstrated the reliability of automated BSI in assessing change in bone scan and served as the foundation for future clinical studies.
This study showed the value of BSI in a homogenous group of prostate cancer patients, with those at high risk receiving primary hormonal therapy.
An automated method can be used to calculate the number of new lesions and changes in BSI in serial bone scans.
In this hypothesis-generating retrospective study, we assessed the discriminatory strength of the upgraded automated BSI in predicting OS in mCRPC patients being treated with enzalutamide.
In the present study, we retrospectively evaluated the discriminatory strength of the automated BSI in predicting overall survival (OS) in mCRPC patients being treated with enzalutamide.
Concordance index (C-index) and its standard error (SE) was used to evaluate the discriminatory strength of the automated BSI in predicting OS [10].
